Track topics on Twitter Track topics that are important to you
IDIS, is the leading authority in the field of named-patient medicine sourcing and supply. Having built an impressive reputation as a reliable and ethical source of named-patient medicines; IDIS prides itself on helping to provide a lifeline to patients and the medical profession.
IDIS supports pharmacists and physicians globally by sourcing and supplying medicines on an ethical named-patient basis. Working with IDIS provides you with instant access to a multitude of global avenues to fulfil your named-patient medicine requirements. IDIS works in partnership with the pharmaceutical and biotechnology industry to establish and deliver pre-launch named-patient management programmes, develop solutions for a discontinued brand, manage temporary supply problems and source and supply medicines for clinical trials. IDIS has specialist in-house expertise in legal and regulatory requirements, technical and clinical support, pharmacovigilance, import/export requirements and distribution and storage to deal with the complexities associated with handling named-patient medicines in an ethical and professional manner.
IDIS HouseChurchfield Road
Phone: 44 (0)1932 824 100
Fax: 44 (0)1932 824 200
Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company, announces that its Idis Global Access (‘Idis GA’) division, ...
The fifth paragraph of release dated June 21, 2017 07:00 AM BST should read: "Under this new agreement, Idis GA will supply and distribute argatroban on an exclusive, unlicensed, ...
Clinigen Group’s Idis Managed Access division and Tesaro have partnered to launch a Managed Access Program (also known as an Early Access Program) in Europe for niraparib, the investigational PARP 1...
Clinigen Group PLC’s (LON:CLIN) Idis Managed Access division and US firm TESARO Inc (NASDAQ:TSRO) are to launch an early stage access program in Europe for niraparib, an investigational tr...
Clinigen Group plc’s (AIM: CLIN, 'Clinigen') Idis Managed Access division and TESARO Inc. (NASDAQ: TSRO) have partnered to launch a Managed Access Program (also known as an Early Acces...
Clinigen Group plc’s (AIM: CLIN, 'Clinigen') Idis Managed Access division and Sarepta Therapeutics Inc. (NASDAQ: SRPT) have initiated a Managed Access Program (MAP) for eteplirs...
There are currently 1.5 million undocumented Asians and Pacific Islanders (APIs) in the US. Undocumented API young adults, in particular, come of age in a challenging political and social climate, but...
The Global Program to Eliminate Lymphatic Filariasis (GPELF) advocates for the treatment of entire endemic communities, in order to achieve its elimination targets. LF is predominantly a rural disease...
The IDIS study aims to develop a new rapid diagnostic test for invasive salmonellosis using samples (blood, urine) collected from patients with fever and healthy controls at the Institute ...
IDIS, is the leading authority in the field of named-patient medicine sourcing and supply. Having built an impressive reputation as a reliable and ethical source of named-patient medicines; IDIS pride...
TradeWithFrance was born out of the cooperation of three founding entities: GBC, IDIS and Ubizquity Consulting.While firm believers in the necessity of establishing Flesh-to-Flesh relationships for an...
We have published hundreds of Idis news stories on BioPortfolio along with dozens of Idis Clinical Trials and PubMed Articles about Idis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Idis Companies in our database. You can also find out about relevant Idis Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...